Sponsor: QIAGENThis groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Sponsor: ThermoFisher ScientificIn this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
Sponsor: ThermoFisher Scientific VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...
Sponsor: Bio-RadIn this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.
Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
Sponsor: DNAnexusThe challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.
Sponsor: Molecular MDCodevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Sponsor: AnglePanelists will discuss how to navigate the clinical diagnostic marketplace and what to consider when developing new assays.
Sponsor: ThermoFisher ScientificCoupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".
Sponsor: ThermoFisher ScientificLarge cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.